TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 16, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Change in Cash (2020 - 2023)

TFA Therapeutics (RAJAF) posted Change in Cash of $4571.0 for Q4 2023, up 360.31% on a QoQ basis from -$1756.0 in Q4 2022, and up 360.31% year-over-year from $993.03 in Q4 2022.

Analysis

TFA Therapeutics (RAJAF) Change in Cash (2020 - 2023) Analysis & Trends

TFA Therapeutics has reported Change in Cash for 3 years, with the latest figure at $4571.0 in Q4 2023.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Colgate Palmolive 69.71 Bn 68.67 Bn 3.30 Bn 35.00 Mn
2 Kenvue 34.22 Bn 33.11 Bn 2.30 Bn 35.00 Mn
3 Kimberly Clark 32.55 Bn 31.72 Bn 1.60 Bn 804.00 Mn
4 Bath & Body Works 3.52 Bn 2.73 Bn 692.00 Mn -
5 Prestige Consumer Healthcare 2.52 Bn 2.46 Bn - -
6 Perrigo 1.88 Bn 1.49 Bn 313.90 Mn 40.20 Mn
7 Edgewell Personal Care 1.25 Bn 854.93 Mn 242.50 Mn 97.40 Mn
8 Herbalife 1.25 Bn 883.17 Mn 1.03 Bn -79.60 Mn
9 TFA Therapeutics 1.02 Bn 1.02 Bn - -
10 Honest Company 611.15 Mn 505.26 Mn 40.36 Mn 15.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 4,571.00
Dec 31, 2022 -1,756.00
Dec 31, 2020 294.00